» Articles » PMID: 16914236

Shielding of Immunogenic Domains in Neisseria Meningitidis FrpB (FetA) by the Major Variable Region

Overview
Journal Vaccine
Date 2006 Aug 18
PMID 16914236
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The meningococcal iron-limitation-inducible outer membrane protein FrpB (FetA) has been shown to induce bactericidal antibodies, and is, therefore, considered a vaccine candidate. However, these antibodies are strain specific and, consistently, epitope mapping showed that they are directed against a region, located in a surface-exposed loop, L5, that displays considerable sequence variability between strains. Here, we attempted to redirect the immune response to more conserved domains of the protein by deleting L5. Immunization with an FrpB protein lacking L5 resulted in a bactericidal antibody response, and epitope mapping showed that these antibodies were directed against loop L3, which also displays considerable sequence variability. To re-direct the immune response further, immunizations were performed with an FrpB protein lacking both L5 and L3. The antibodies obtained were not bactericidal. Furthermore, the bactericidal antibodies against L3 were only bactericidal in the absence of L5, and immunofluorescence microscopy experiments showed that L5 efficiently shields other immunogenic cell surface-exposed epitopes outside of this region on living cells. Whereas the ability of micro-organisms to vary surface-exposed domains that are targets for protective immunity has long been established, the current work shows that such domains can be remarkably efficient in shielding other, more conserved epitopes.

Citing Articles

Structural and functional insights into iron acquisition from lactoferrin and transferrin in Gram-negative bacterial pathogens.

Chan C, Ng D, Fraser M, Schryvers A Biometals. 2022; 36(3):683-702.

PMID: 36418809 PMC: 10182148. DOI: 10.1007/s10534-022-00466-6.


Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.

Rollier C, Dold C, Marsay L, Linder A, Green C, Sadarangani M mSphere. 2022; 7(1):e0067421.

PMID: 35080470 PMC: 8791392. DOI: 10.1128/msphere.00674-21.


Subversion of nutritional immunity by the pathogenic Neisseriae.

Cornelissen C Pathog Dis. 2017; 76(1).

PMID: 29045638 PMC: 6251569. DOI: 10.1093/femspd/ftx112.


FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression.

Sanders H, Norheim G, Chan H, Dold C, Vipond C, Derrick J PLoS One. 2015; 10(10):e0140345.

PMID: 26466091 PMC: 4605655. DOI: 10.1371/journal.pone.0140345.


An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity.

Norheim G, Sanders H, Mellesdal J, Sundfor I, Chan H, Brehony C PLoS One. 2015; 10(9):e0134353.

PMID: 26390123 PMC: 4577077. DOI: 10.1371/journal.pone.0134353.